Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Despite positive job market trends, economy continues to face challenges

Unemployment data released today by the U.S. Department of Labor indicates that although job losses have slowed significantly, the economy continues to face challenges, noted the Retail Industry Leaders Association (RILA).

5 Dec 2009

Iowa business researchers use efficient manufacturing principles to help contain rising health care costs

A group of researchers at the University of Iowa's Tippie College of Business is using the principles of more efficient manufacturing processes in an effort to help contain ever-increasing health care costs.

5 Dec 2009

DOE and USDA announce $600 million grants and loan guarantees to build new biorefinery projects

The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.

5 Dec 2009

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines.

4 Dec 2009

Weight loss - an effective treatment for sleep apnoea in obese men

For obese men, a dramatic weight loss can be an effective way to improve moderate to severe sleep apnoea, scientists at the Swedish medical university Karolinska Institutet report. Those with severe sleep apnoea when the study began benefited most from weight loss.

4 Dec 2009

Genzyme announces reopening of enrollment in its Pompe disease ATAP program

Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.

4 Dec 2009

NeoPharm and Diosynth settle dispute resolution

NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP (“Diosynth”). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.

4 Dec 2009

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal’s fourth liquid approval.

3 Dec 2009

Ingredia Nutritionals to distribute Nutrition 21's Chromax and Diachrome ingredients in the EU

Nutrition 21, Inc., the developer and marketer of nutritional ingredients for the dietary supplement, and functional food and beverage markets announced today that chromium picolinate has been added to the approved list of ingredients allowed to be used in food supplements in the European Union (EU).

3 Dec 2009

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

3 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept, Inc. today announced a collaboration and license agreement for the global development and commercialization of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).

3 Dec 2009

Roche ships additional quantities of Tamiflu oral suspension

Roche announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

3 Dec 2009

New study reveals smokeless tobacco products contain high levels of cancer-causing substances

A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.

3 Dec 2009

Jiangsu Yanshen Biological Technology Stock suspends production of all products

Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that its subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen") has suspended production of all its products in order to conduct an internal inspection and improve its quality control systems.

2 Dec 2009

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.

2 Dec 2009

Genzyme ships vials of newly produced Cerezyme

Genzyme Corporation announced today that it has begun shipping vials of newly produced Cerezyme® (imiglucerase for injection) manufactured at its Allston Landing plant.

2 Dec 2009

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

The Georgia Institute of Technology has been awarded a U.S. Air Force Center of Excellence to design nanostructures for energy harvesting and adaptive materials, and to develop tools to optimize critical cognitive processes of the modern warfighter.

2 Dec 2009

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A - a rare, inherited blood-clotting disorder - now have a new treatment option with the introduction of XYNTHA(TM), a recombinant factor VIII product for both the control and prevention of bleeding episodes and surgical prophylaxis.

2 Dec 2009

ZEGERID OTC, a proton pump inhibitor receives FDA approval

Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.

2 Dec 2009

Manufacturing News and Research

Further Reading

Despite positive job market trends, economy continues to face challenges

Iowa business researchers use efficient manufacturing principles to help contain rising health care costs

DOE and USDA announce $600 million grants and loan guarantees to build new biorefinery projects

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Weight loss - an effective treatment for sleep apnoea in obese men

Genzyme announces reopening of enrollment in its Pompe disease ATAP program

NeoPharm and Diosynth settle dispute resolution

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Ingredia Nutritionals to distribute Nutrition 21's Chromax and Diachrome ingredients in the EU

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

Roche ships additional quantities of Tamiflu oral suspension

New study reveals smokeless tobacco products contain high levels of cancer-causing substances

Jiangsu Yanshen Biological Technology Stock suspends production of all products

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Genzyme ships vials of newly produced Cerezyme

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Canadians with hemophilia A can use new treatment option, XYNTHA

ZEGERID OTC, a proton pump inhibitor receives FDA approval

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News